This robust connectivity suggests that neuromodulation techniques, such as transcranial magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS), targeting the DLPFC could indirectly modulate MCC activity, potentially alleviating cognitive and emotional symptoms in mTBI patients. The gene discussed is MCC; the disease is concussion.